PROGYNY INC (PGNY) Stock Price, Quote, News and Summary
NASDAQ:PGNY - Nasdaq - US74340E1038 - Common Stock
PGNY Quote and Key Statistics
PROGYNY INC
NASDAQ:PGNY (1/21/2025, 8:20:21 PM)
After market: 21.5 +0.02 (+0.09%)21.48
+0.48 (+2.29%)
PGNY Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.03% | ||
| ROA | 8.68% | ||
| ROE | 13.17% | ||
| Debt/Equity | 0 |
PGNY Performance and Technical Analysis
PGNY Ownership and Analysts
PGNY Latest News and Analysis
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women’s health benefits...
Progyny, Inc. (PGNY) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
Anticipates Fourth Quarter and Full Year Results to be Slightly Above Previously Provided Financial Guidance
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY)...
About PGNY
Company Profile
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 563 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Company Info
PROGYNY INC
1359 Broadway
New York City NEW YORK 10018 US
CEO: David Schlanger
Employees: 565
Company Website: https://www.progyny.com/
Investor Relations: https://investors.progyny.com/
Phone: 12128883124
PGNY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 18.8 | 483.14B | ||
| ELV | ELEVANCE HEALTH INC | 11.2 | 90.27B | ||
| HUM | HUMANA INC | 15.61 | 34.28B | ||
| CNC | CENTENE CORP | 9.43 | 32.14B | ||
| MOH | MOLINA HEALTHCARE INC | 13.53 | 17.01B | ||
| HQY | HEALTHEQUITY INC | 34.12 | 9.08B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | N/A | 2.79B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 2.12B | ||
| NEUE | NEUEHEALTH INC | 5.58 | 61.10M |